Oncogenic potential of hepatitis B virus.
Katsuro Koike(Kanazawa University), Midori Kobayashi(FIND), Masayuki Arii(The Cancer Institute Hospital), Ikuo Nakamura, Sanami Takada(Chiba University), Yoshitaka Hayashi(Nagoya University), Masayuki Kawada, Yumiko Shirakata(The Cancer Institute Hospital), Katsuyuki Yaginuma(The Cancer Institute Hospital)
PubMed
August 17, 1983
Cited by 64
Related Papers
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.
|Proceedings of the National Academy of Sciences|1987|253
Whole-body MRI for Detecting Metastatic Bone Tumor: Diagnostic Value of Diffusion-weighted Images
|Magnetic Resonance in Medical Sciences|2007|181
The × Gene of Hepatitis B Virus Induced Growth Stimulation and Tumorigenic Transformation of Mouse NIH3T3 Cells
|Japanese Journal of Cancer Research|1989|170
Molecular clock of silent substitution: At least six-fold preponderance of silent changes in mitochondrial genes over those in nuclear genes
|Journal of Molecular Evolution|1982|155
Hepatitis B Virus X Protein Induces Cell Death by Causing Loss of Mitochondrial Membrane Potential
|Journal of Biological Chemistry|2003|155